CHADS2 score
WikiDoc Resources for CHADS2 score |
Articles |
---|
Most recent articles on CHADS2 score Most cited articles on CHADS2 score |
Media |
Powerpoint slides on CHADS2 score |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on CHADS2 score at Clinical Trials.gov Clinical Trials on CHADS2 score at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on CHADS2 score
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on CHADS2 score Discussion groups on CHADS2 score Patient Handouts on CHADS2 score Directions to Hospitals Treating CHADS2 score Risk calculators and risk factors for CHADS2 score
|
Healthcare Provider Resources |
Causes & Risk Factors for CHADS2 score |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
CHADS Score or CHADS2 Score is an clinical prediction rule for estimating the risk of stroke in patients with atrial fibrillation (AFIB), a common and usually benign heart arrythmia. It is used to determine the degree of anticoagulation therapy required,[1] since AFIB can cause the stasis of blood in the heart chambers, leading to the formation of a mural thrombus that can dislodge into the blood flow, reaching the brain and causing a stroke. A high CHADS score corresponds to a greater risk, and vice-versa. The CHADS/CHADS2 algorithm was validated by a cohort study published in JAMA in 2001 using 1,733 Atrial fibrillation patients tracked through Medicare claims.[2]
Algorithm
The CHADS/CHADS2 algorithm is as follows:[3]
C: | Congestive heart failure | = 1 point |
H: | Hypertension (systolic >160 mmHg) | = 1 point |
A: | Age >75 years | = 1 point |
D: | Diabetes | = 1 point |
S: | Prior Transient ischemic attack or Stroke | = 2 points |
Risk of Stroke
According to the findings of the JAMA study, the risk of stroke as a percentage per year is:
Score | Risk of Stroke Per Year | 95% CIs from JAMA Study |
---|---|---|
0 | 1.9% | |
1 | 2.8% | |
2 | 4.0% | |
3 | 5.9% | |
4 | 8.5% | |
5 | 12.5% | |
6 | 18.2% |
Recommendations for Anticoagulation
The following treatment strategies were recommended by the authors of theJAMA and Circulation articles:
Score | Risk | Anticoagulation Therapy | Considerations |
---|---|---|---|
0 | Low | Aspirin | 325 mg/day most likely to offer benefit, although lower doses may be similarly efficacious |
1-2 | Moderate | Aspirin or Warfarin | Raise INR to 2.0-3.0, depending on factors such as patient preference |
3+ | High | Warfarin | Raise INR to 2.0-3.0, unless contraindicated (e.g., history of falls, clinically significant GI bleeding, inability to obtain regular INR screening) |
Criticism of CHADS
The main criticism of the CHADS/CHADS2 scoring system is that someone with atrial fibrillation and a previous history of stroke, but no other risk factors (i.e. CHADS2 Score = 2), is only classified as moderate risk, whereas that person is in fact at high risk of another stroke.
References
- ↑ Gage BF, van Walraven C, Pearce L; et al. (2004). "Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin". Circulation. 110 (16): 2287&ndash, 92. doi:10.1161/01.CIR.0000145172.55640.93. PMID 15477396.
- ↑ Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001). "Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation". JAMA. 285 (22): 2864–70. PMID 11401607.
- ↑ "Risk of Stroke with AF". VA Palo Alto Medical Center and at Stanford University: the Sportsmedicine Program and the Cardiomyopathy Clinic. Retrieved 2007-09-14.